vida: research 2026 04 28 #4750

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 10:30:21 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 10:30 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 10:30 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) that align with publicly available information about the GLP-1 market.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is contained within the research-journal.md file and the associated inbox files are unique source metadata.
  3. Confidence calibration — This PR does not contain claims with confidence levels, as it is a research journal entry and source files.
  4. Wiki links — This PR does not contain any wiki links.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) that align with publicly available information about the GLP-1 market. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is contained within the `research-journal.md` file and the associated inbox files are unique source metadata. 3. **Confidence calibration** — This PR does not contain claims with confidence levels, as it is a research journal entry and source files. 4. **Wiki links** — This PR does not contain any wiki links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched in this PR, so there is no risk of duplicate evidence injection into existing claims.

3. Confidence:
No claims are present in this PR (only journal entries and sources), so confidence calibration does not apply.

4. Wiki links:
The journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no wiki link syntax is used that would indicate broken references.

5. Source quality:
The nine source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), market data (employer coverage percentages, revenue figures), and concrete events (bankruptcy filing May 2025, IPO June 2025) that are verifiable and appropriate for the research questions being investigated.

6. Specificity:
No claims are present in this PR to evaluate for specificity; the journal entry makes falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not KB claims.

Verdict reasoning: This PR adds research documentation and source materials without introducing any claims to the knowledge base. All content is appropriately structured for its type (research journal + sources). No schema violations, no confidence miscalibration, no factual issues detected in the research notes themselves.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This is a research journal entry documenting a new investigation session (2026-04-28) with nine supporting source files; no claims are being enriched in this PR, so there is no risk of duplicate evidence injection into existing claims. **3. Confidence:** No claims are present in this PR (only journal entries and sources), so confidence calibration does not apply. **4. Wiki links:** The journal entry references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no [[wiki link]] syntax is used that would indicate broken references. **5. Source quality:** The nine source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), market data (employer coverage percentages, revenue figures), and concrete events (bankruptcy filing May 2025, IPO June 2025) that are verifiable and appropriate for the research questions being investigated. **6. Specificity:** No claims are present in this PR to evaluate for specificity; the journal entry makes falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not KB claims. **Verdict reasoning:** This PR adds research documentation and source materials without introducing any claims to the knowledge base. All content is appropriately structured for its type (research journal + sources). No schema violations, no confidence miscalibration, no factual issues detected in the research notes themselves. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 10:31:59 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 10:31:59 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 10:34:27 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.